Treatment patterns of antidiabetic and kidney protective therapies among patients with type 2 diabetes mellitus and chronic kidney disease in Colombia. The KDICO descriptive study.

Manuel E Machado-Duque,Andres Gaviria-Mendoza,Luis F Valladales-Restrepo,Juan Sebastian Franco,Maria de Rosario Forero,David Vizcaya,Jorge E Machado-Alba

Diabetology & metabolic syndrome（2023）

引用 0|浏览0

暂无评分

摘要

In Colombia, the majority of patients with type 2 diabetes mellitus and CKD identified in this study were treated with antidiabetic and protective medications to ensure adequate metabolic, cardiovascular, and renal control. The management of type 2 diabetes mellitus and CKD may be improved if the beneficial properties of new groups of antidiabetics (SGLT2i, GLP1a), as well as novel mineralocorticoid receptor antagonists, are considered.

查看译文

关键词

Diabetes Mellitus, type 2, Chronic kidney failure, Metformin, Dipeptidyl-peptidase IV inhibitors, Angiotensin receptor antagonists, Sodium-glucose transporter 2 inhibitors, Glucagon-like peptide 1, Pharmacoepidemiology

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要